Development of daptomycin for Gram-positive infections

被引:238
作者
Tally, FP [1 ]
DeBruin, MF [1 ]
机构
[1] Cubist Pharmaceut Inc, Cambridge, MA 02139 USA
关键词
D O I
10.1093/jac/46.4.523
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
[No abstract available]
引用
收藏
页码:523 / 526
页数:4
相关论文
共 32 条
[1]   DAPTOMYCIN DISRUPTS MEMBRANE-POTENTIAL IN GROWING STAPHYLOCOCCUS-AUREUS [J].
ALBORN, WE ;
ALLEN, NE ;
PRESTON, DA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (11) :2282-2287
[2]   THE ACTIVITY OF DAPTOMYCIN ON ENTEROCOCCUS-FAECIUM PROTOPLASTS - INDIRECT EVIDENCE SUPPORTING A NOVEL MODE OF ACTION ON LIPOTEICHOIC ACID SYNTHESIS [J].
BOARETTI, M ;
CANEPARI, P ;
LLEO, MD ;
SATTA, G .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 31 (02) :227-235
[3]   INVITRO POSTANTIBIOTIC EFFECT OF DAPTOMYCIN (LY146032) AGAINST ENTEROCOCCUS-FAECALIS AND METHICILLIN-SUSCEPTIBLE AND METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS STRAINS [J].
BUSH, LM ;
BOSCIA, JA ;
WENDELER, M ;
PITSAKIS, PG ;
KAYE, D .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (08) :1198-1200
[4]   LIPOTEICHOIC ACID AS A NEW TARGET FOR ACTIVITY OF ANTIBIOTICS - MODE OF ACTION OF DAPTOMYCIN (LY146032) [J].
CANEPARI, P ;
BOARETTI, M ;
LLEO, MD ;
SATTA, G .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (06) :1220-1226
[5]   COMPARATIVE EFFICACY OF DAPTOMYCIN, VANCOMYCIN, AND CLOXACILLIN FOR THE TREATMENT OF STAPHYLOCOCCUS-AUREUS ENDOCARDITIS IN RATS AND ROLE OF TEST CONDITIONS IN THIS DETERMINATION [J].
CANTONI, L ;
GLAUSER, MP ;
BILLE, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (12) :2348-2353
[6]   TREATMENT OF CLOSTRIDIUM-DIFFICILE COLITIS IN HAMSTERS WITH A LIPOPEPTIDE ANTIBIOTIC, LY146032 [J].
DONG, MY ;
CHANG, TW ;
GORBACH, SL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (07) :1135-1136
[7]   Nosocomial bloodstream infections in United States hospitals: A three-year analysis [J].
Edmond, MB ;
Wallace, SE ;
McClish, DK ;
Pfaller, MA ;
Jones, RN ;
Wenzel, RP .
CLINICAL INFECTIOUS DISEASES, 1999, 29 (02) :239-244
[8]   PHARMACODYNAMICS OF DAPTOMYCIN AND VANCOMYCIN ON ENTEROCOCCUS-FAECALIS AND STAPHYLOCOCCUS-AUREUS DEMONSTRATED BY STUDIES OF INITIAL KILLING AND POSTANTIBIOTIC EFFECT AND INFLUENCE OF CA2+ AND ALBUMIN ON THESE DRUGS [J].
HANBERGER, H ;
NILSSON, LE ;
MALLER, R ;
ISAKSSON, B .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (09) :1710-1716
[9]   TREATMENT OF EXPERIMENTAL ENDOCARDITIS CAUSED BY A BETA-LACTAMASE-PRODUCING STRAIN OF ENTEROCOCCUS-FAECALIS WITH HIGH-LEVEL RESISTANCE TO GENTAMICIN [J].
HINDES, RG ;
WILLEY, SH ;
ELIOPOULOS, GM ;
RICE, LB ;
ELIOPOULOS, CT ;
MURRAY, BE ;
MOELLERING, RC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (07) :1019-1022
[10]  
JACOBUS NV, 1998, 38 INT C ANT AG CHEM, P260